Pharma Mar SA (PHMMF)
106.48
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Pharma Mar Total Liabilities (Quarterly) : 155.18M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 155.18M |
| December 31, 2025 | 168.51M |
| September 30, 2025 | 164.26M |
| June 30, 2025 | 165.28M |
| March 31, 2025 | 145.64M |
| December 31, 2024 | 145.42M |
| September 30, 2024 | 168.48M |
| June 30, 2024 | 145.46M |
| March 31, 2024 | 152.53M |
| December 31, 2023 | 163.25M |
| September 30, 2023 | 151.63M |
| June 30, 2023 | 161.89M |
| March 31, 2023 | 170.34M |
| December 31, 2022 | 182.26M |
| September 30, 2022 | |
| June 30, 2022 | 192.19M |
| March 31, 2022 | 196.08M |
| December 31, 2021 | 217.14M |
| September 30, 2021 | 236.99M |
| June 30, 2021 | 246.30M |
| March 31, 2021 | 255.72M |
| December 31, 2020 | 278.40M |
| September 30, 2020 | 271.56M |
| June 30, 2020 | 279.36M |
| March 31, 2020 | 217.51M |
| Date | Value |
|---|---|
| December 31, 2019 | 129.53M |
| September 30, 2019 | 132.73M |
| June 30, 2019 | 152.05M |
| March 31, 2019 | 178.09M |
| December 31, 2018 | 157.85M |
| September 30, 2018 | 170.29M |
| June 30, 2018 | 192.04M |
| March 31, 2018 | 201.70M |
| December 31, 2017 | 197.82M |
| September 30, 2017 | 197.99M |
| June 30, 2017 | 204.16M |
| March 31, 2017 | 182.41M |
| December 31, 2016 | 158.00M |
| September 30, 2016 | 172.41M |
| June 30, 2016 | 179.85M |
| March 31, 2016 | 173.81M |
| December 31, 2015 | 123.84M |
| September 30, 2015 | 188.40M |
| June 30, 2015 | 167.78M |
| March 31, 2015 | 122.66M |
| December 31, 2014 | 134.85M |
| September 30, 2014 | 186.68M |
| June 30, 2014 | 207.10M |
| March 31, 2014 | 187.60M |
| December 31, 2013 | 155.68M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Oryzon Genomics SA | 26.97M |
| Grifols SA | 14.09B |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alkermes Plc | 2.507B |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 443.90M |
| Shareholders Equity (Quarterly) | 287.67M |
| Debt to Equity Ratio | 0.1904 |
| Current Ratio | 3.065 |
| Net Debt Paydown Yield | -0.03% |